NL-OMON46006已完成不适用
A randomized, open-label, crossover study to compare the ratio of pharmacokinetics between Orgaran® and Clexane® in healthy subjects with an historical study. - Orgaran® PK study.
Aspen Global Incorporated (AGI)0 个研究点目标入组 28 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •healthy male subjects
- •18-30 years of age
- •BMI 18.0-30.0 kg/m2
- •non smokers or less than 10 cigarettes per day
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
A randomized, open-label, crossover study to evaluate ICS/LABA treatment versus LAMA/LABA treatment in COPD with eosinophilic inflammatioCOPDJPRN-UMIN000024905Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital25
进行中（未招募）
1 期
A randomized, open-label, cross-over study to explore a potential involvement of a dopamine related dysfunction as a mechanism behind bruxism - Studera effekt av en dopaminagonist på patienter med bruxismPatients with severe oral bruxism according to Polysomnographic cut-off criteria for bruxism: more than 4 bruxism episodes per hour, more than 6 bruxism bursts per episode and/or 25 bruxism bursts per hour of sleep and at least 2 episodes with grinding sounds.MedDRA version: 12.1Level: HLGTClassification code 10028037Term: Movement disorders (incl parkinsonism)EUCTR2009-010282-23-SETandvården SU/Mölndal20
已完成
不适用
An open-label, randomized crossover study to evaluate the pharmacokinetics, bioavailability, bioequivalence, and food effect following administration of Oxybate Formulations in healthy subjects.NL-OMON41817Jazz Pharmaceuticals60
已完成
不适用
An open-label, randomized crossover study to evaluate the effect of ASP1941 on the pharmacokinetics, pharmacodynamics, safety and tolerability of glimepiride in healthy subjects and vice versa.NL-OMON34715Astellas Pharma26
已完成
1 期
Comparative bioavailability study of TRC041266 Powder with TRC4186 Tablet in Healthy Human Subjects.CTRI/2018/08/015226Torrent Pharamceutical Ltd36